Study of SPG302 in Adults With Schizophrenia

NCT06442462 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: SPG302
DRUG: Placebo

Sponsor

Spinogenix